Cost effectiveness of Avelumab for metastatic Merkel cell carcinoma

Bullement, A., Nathan, P., Willis, A. et al. (6 more authors) (2019) Cost effectiveness of Avelumab for metastatic Merkel cell carcinoma. PharmacoEconomics - Open, 3 (3). pp. 377-390. ISSN 2509-4262



Copyright, Publisher and Additional Information: © The Author(s) 2019. Open Access: This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (, which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
  • Published (online): 24 January 2019
  • Published: September 2019
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > School of Health and Related Research (Sheffield)
Depositing User: Symplectic Sheffield
Date Deposited: 12 Jan 2021 14:26
Last Modified: 12 Jan 2021 22:49
Status: Published
Publisher: Springer Science and Business Media LLC
Refereed: Yes
Identification Number:
Related URLs: